Kontiki Capital reports 5.03% GCI Liberty (GLIBA) Series C ownership in 13G
Rhea-AI Filing Summary
GCI Liberty Inc. received a Schedule 13G from Kontiki Capital entities and Gregard Heje reporting a passive stake in its Series C common stock. The filing states beneficial ownership of 1,796,821 shares, or 5.03% of the class, based on 35,713,233 Series C shares outstanding following the issuer’s rights offering that concluded on December 17, 2025.
The shares are held by two private funds advised by Kontiki Capital Management (HK) Ltd., with control cascading through Kontiki Capital Management (Cayman) Ltd. to Gregard Heje. The filers certify the position was not acquired to change or influence control of GCI Liberty.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stake in GCI Liberty (GLIBA) is reported in this Schedule 13G?
The Schedule 13G reports beneficial ownership of 1,796,821 Series C shares of GCI Liberty, representing 5.03% of that class. This percentage is calculated against 35,713,233 Series C shares outstanding following the company’s rights offering that concluded on December 17, 2025.
Who are the reporting persons in the GCI Liberty (GLIBA) Schedule 13G?
The reporting persons are Kontiki Capital Management (HK) Ltd., Kontiki Capital Management (Cayman) Ltd., and Gregard Heje. They are collectively identified as the filing persons and are deemed beneficial owners of the reported GCI Liberty Series C common stock stake.
Is the GCI Liberty (GLIBA) position described as passive or controlling?
The position is described as passive. The signatories certify the securities were not acquired and are not held for the purpose of changing or influencing control of GCI Liberty, other than activities solely in connection with a nomination under the referenced SEC rule.
How was the 5.03% ownership in GCI Liberty (GLIBA) calculated?
The 5.03% ownership is based on 35,713,233 Series C common shares of GCI Liberty outstanding. That figure reflects the total Series C shares following full subscription of the rights offering that concluded on December 17, 2025, as described in the company’s prospectus.